Nexalin Technology (NXL) Shares Outstanding (Entity) (2021 - 2026)
Nexalin Technology (NXL) Shares Outstanding (Entity) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | 1.73 Bn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | 383.57 Mn |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | 576.60 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 377.40 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 451.69 Mn |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | 977.43 Mn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 97.50 Mn |
| 10 | Nexalin Technology | 7.11 Mn | 6.11 Mn | 8,897.00 | 22.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.00 Mn |
| Mar 31, 2026 | 20.58 Mn |
| Dec 31, 2025 | 19.19 Mn |
| Sep 30, 2025 | 18.19 Mn |
| Jun 30, 2025 | 17.42 Mn |
| Mar 31, 2025 | 13.33 Mn |
| Dec 31, 2024 | 9.22 Mn |
| Sep 30, 2024 | 12.86 Mn |
| Jun 30, 2024 | 7.59 Mn |
| Mar 31, 2024 | 7.44 Mn |
| Dec 31, 2023 | 7.44 Mn |
| Sep 30, 2023 | 7.44 Mn |
| Jun 30, 2023 | 7.29 Mn |
| Mar 31, 2023 | 7.29 Mn |
| Dec 31, 2022 | 5.57 Mn |
| Sep 30, 2022 | 5.19 Mn |
| Jun 30, 2022 | 4.91 Mn |
| Mar 31, 2022 | 4.91 Mn |
| Dec 31, 2021 | 4.88 Mn |
| Sep 30, 2021 | 4.50 Mn |